Department of Health officials have asked the watchdog to evaluate the clinical and cost effectiveness of giving semaglutide injections to obese children aged 12 to 17, “in addition to healthy nutrition and increased physical activity”, the Observer can reveal.
See also:
- Can drugs fix the UK’s adolescent obesity crisis? The Observer
No comments:
Post a Comment